• Home
  • Welcome
  • CAD & Treatments
  • Donation
  • Resources
  • Webinar Resources
  • Register Web Series
  • Latest News & Events
  • Members
  • Specialists
  • Media
  • Clinical Trials
  • Our Stories
  • Stay In The Know
  • Medical Advisors
  • Contact Us
  • Privacy & Policies
  • E-Learning Education
  • Impact ISPOR
  • Observational Study
  • More
    • Home
    • Welcome
    • CAD & Treatments
    • Donation
    • Resources
    • Webinar Resources
    • Register Web Series
    • Latest News & Events
    • Members
    • Specialists
    • Media
    • Clinical Trials
    • Our Stories
    • Stay In The Know
    • Medical Advisors
    • Contact Us
    • Privacy & Policies
    • E-Learning Education
    • Impact ISPOR
    • Observational Study
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Welcome
  • CAD & Treatments
  • Donation
  • Resources
  • Webinar Resources
  • Register Web Series
  • Latest News & Events
  • Members
  • Specialists
  • Media
  • Clinical Trials
  • Our Stories
  • Stay In The Know
  • Medical Advisors
  • Contact Us
  • Privacy & Policies
  • E-Learning Education
  • Impact ISPOR
  • Observational Study

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

NEWS AND EVENTS

FDA | Enjaymo®

FDA | Enjaymo®

FDA | Enjaymo®

   The FDA has approved expanded use of Enjaymo to US patients who are not transfusion dependent.

Learn more

Sanofi Genezyme

FDA | Enjaymo®

FDA | Enjaymo®

  Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin disease

Learn more

Sanofi Genezyme

FDA | Enjaymo®

Sanofi Genezyme

Food and Drug Administration (FDA) approves Enjaymo (sutimlimab-jome)

Learn more

Larry Luxner

Webinar Series & Presentation

Rituxan & Treatments

Article: CAD Foundation Strives to Increase Knowledge of this disease.

Learn more

Rituxan & Treatments

Webinar Series & Presentation

Rituxan & Treatments

 CAD Foundation Summit Series - March 23/2021

Learn more

Webinar Series & Presentation

Webinar Series & Presentation

Webinar Series & Presentation

February 23, 2021 CAD/COVID & Dr. Furman's Webinar January 19, 2021 

Learn more

Insights and Answers

Info For Medical Professionals

Webinar Series & Presentation

 International Society for Pharmacoeconomics and Outcomes Research 

Learn more

Info For Medical Professionals

Info For Medical Professionals

Info For Medical Professionals

Medical Advisors who have endorsed CADF 

Feb 19, 2021

Learn more

Corona Virus & CAD

Info For Medical Professionals

Info For Medical Professionals

News Release, December, 07 2020

Learn more

FDA Complete Response

Dr. Catherine Elizabeth Connolly

Complete the Questionaire

This is not a roadblock; it's only a detour. 

Learn more

Complete the Questionaire

Dr. Catherine Elizabeth Connolly

Complete the Questionaire

Survey on the experience of patients living with cold agglutinin disease

Learn more

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

My Dad's diagnosis of CAD. Part 2: Slowing Down  

Learn more

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

Dr. Catherine Elizabeth Connolly

Understanding through experience, My Dad’s diagnosis of CAD Part 1.  

Learn more

Sanofi's Biologics

Dr. Catherine Elizabeth Connolly

Sanofi's Biologics

FDA grants priority review of Sutimlimab. Potenial first approved treatment.

Learn more

Impact - Covid-19

Dr. Catherine Elizabeth Connolly

Sanofi's Biologics

In support of rare disease patients that are impacted.

Learn more

NEWS lETTERS

Dec Edition #3

Sept Edition #2

Sept Edition #2

Welcome to CADdy News Our 3nd edition newsletter 

December 2020 Edition

Sept Edition #2

Sept Edition #2

Sept Edition #2

Welcome to CADdy News Our 2nd edition newsletter 

September 2020 Edition

July Edition #1

Sept Edition #2

July Edition #1

Welcome to CADdy News Our 1st edition newsletter

July 2020 Edition

Copyright © 2022 Cold Agglutinin Disease Foundation - All Rights Reserved.

Privacy & Policies

Contact Us: info@cadfadvocacy.org

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept